First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.

about

Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease.

P2860

Q55269457-1A2E6D3B-8A26-4D50-B782-A6F76DA98E04

P2860

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.

Item

http://www.wikidata.org/entity/Q50098252

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

First Evidence: TRAP-Induced P ...... in Patients Receiving Xabans.

@en

First Evidence: TRAP-Induced P ...... in Patients Receiving Xabans.

@nl

type

Item

label

First Evidence: TRAP-Induced P ...... in Patients Receiving Xabans.

@en

First Evidence: TRAP-Induced P ...... in Patients Receiving Xabans.

@nl

prefLabel

First Evidence: TRAP-Induced P ...... in Patients Receiving Xabans.

@en

First Evidence: TRAP-Induced P ...... in Patients Receiving Xabans.

@nl

P1476

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans

@en

P2093

Frantisek Kovar

http://www.w3.org/2001/XMLSchema#string

Frantisek Nehaj

http://www.w3.org/2001/XMLSchema#string

Jan Stasko

http://www.w3.org/2001/XMLSchema#string

Jela Ivankova

http://www.w3.org/2001/XMLSchema#string

Juraj Sokol

http://www.w3.org/2001/XMLSchema#string

Marian Mokan

http://www.w3.org/2001/XMLSchema#string

Michal Mokan

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment

Guidance for the treatment of deep vein thrombosis and pulmonary embolism

Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

Signaling during platelet adhesion and activation

Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies.

Protease-activated receptors in hemostasis, thrombosis and vascular biology.

P304

914-919

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029617734310

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29050502

http://www.w3.org/2001/XMLSchema#string

P932

6714725

http://www.w3.org/2001/XMLSchema#string

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.

about

P2860

P2860

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932